Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
Amifampridine Tablets, 10 mg are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older.
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
Subscribe To Our Newsletter & Stay Updated
